Cargando…

The Role of Phytochemicals and Gut Microbiome in Atherosclerosis in Preclinical Mouse Models

Gut microbiome alterations have recently been linked to many chronic conditions including cardiovascular disease (CVD). There is an interplay between diet and the resident gut microbiome, where the food eaten affects populations of certain microbes. This is important, as different microbes are assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Centner, Ann M., Khalili, Leila, Ukhanov, Vladimir, Kadyan, Saurabh, Nagpal, Ravinder, Salazar, Gloria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005405/
https://www.ncbi.nlm.nih.gov/pubmed/36904211
http://dx.doi.org/10.3390/nu15051212
_version_ 1784905072164995072
author Centner, Ann M.
Khalili, Leila
Ukhanov, Vladimir
Kadyan, Saurabh
Nagpal, Ravinder
Salazar, Gloria
author_facet Centner, Ann M.
Khalili, Leila
Ukhanov, Vladimir
Kadyan, Saurabh
Nagpal, Ravinder
Salazar, Gloria
author_sort Centner, Ann M.
collection PubMed
description Gut microbiome alterations have recently been linked to many chronic conditions including cardiovascular disease (CVD). There is an interplay between diet and the resident gut microbiome, where the food eaten affects populations of certain microbes. This is important, as different microbes are associated with various pathologies, as they can produce compounds that are disease-promoting or disease-protecting. The Western diet negatively affects the host gut microbiome, ultimately resulting in heightened arterial inflammation and cell phenotype changes as well as plaque accumulation in the arteries. Nutritional interventions including whole foods rich in fiber and phytochemicals as well as isolated compounds including polyphenols and traditional medicinal plants show promise in positively influencing the host gut microbiome to alleviate atherosclerosis. This review investigates the efficacy of a vast array of foods and phytochemicals on host gut microbes and atherosclerotic burden in mice. Reduction in plaque by interventions was associated with increases in bacterial diversity, reduction in the Firmicutes/Bacteroidetes (F/B) ratio, and upregulation of Akkermansia. Upregulation in CYP7 isoform in the liver, ABC transporters, bile acid excretion, and the level of acetic acid, propionic acid, and butyric acid were also noted in several studies reducing plaque. These changes were also associated with attenuated inflammation and oxidative stress. In conclusion, an increase in the abundance of Akkermansia with diets rich in polyphenols, fiber, and grains is likely to reduce plaque burden in patients suffering from CVD.
format Online
Article
Text
id pubmed-10005405
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100054052023-03-11 The Role of Phytochemicals and Gut Microbiome in Atherosclerosis in Preclinical Mouse Models Centner, Ann M. Khalili, Leila Ukhanov, Vladimir Kadyan, Saurabh Nagpal, Ravinder Salazar, Gloria Nutrients Systematic Review Gut microbiome alterations have recently been linked to many chronic conditions including cardiovascular disease (CVD). There is an interplay between diet and the resident gut microbiome, where the food eaten affects populations of certain microbes. This is important, as different microbes are associated with various pathologies, as they can produce compounds that are disease-promoting or disease-protecting. The Western diet negatively affects the host gut microbiome, ultimately resulting in heightened arterial inflammation and cell phenotype changes as well as plaque accumulation in the arteries. Nutritional interventions including whole foods rich in fiber and phytochemicals as well as isolated compounds including polyphenols and traditional medicinal plants show promise in positively influencing the host gut microbiome to alleviate atherosclerosis. This review investigates the efficacy of a vast array of foods and phytochemicals on host gut microbes and atherosclerotic burden in mice. Reduction in plaque by interventions was associated with increases in bacterial diversity, reduction in the Firmicutes/Bacteroidetes (F/B) ratio, and upregulation of Akkermansia. Upregulation in CYP7 isoform in the liver, ABC transporters, bile acid excretion, and the level of acetic acid, propionic acid, and butyric acid were also noted in several studies reducing plaque. These changes were also associated with attenuated inflammation and oxidative stress. In conclusion, an increase in the abundance of Akkermansia with diets rich in polyphenols, fiber, and grains is likely to reduce plaque burden in patients suffering from CVD. MDPI 2023-02-28 /pmc/articles/PMC10005405/ /pubmed/36904211 http://dx.doi.org/10.3390/nu15051212 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Centner, Ann M.
Khalili, Leila
Ukhanov, Vladimir
Kadyan, Saurabh
Nagpal, Ravinder
Salazar, Gloria
The Role of Phytochemicals and Gut Microbiome in Atherosclerosis in Preclinical Mouse Models
title The Role of Phytochemicals and Gut Microbiome in Atherosclerosis in Preclinical Mouse Models
title_full The Role of Phytochemicals and Gut Microbiome in Atherosclerosis in Preclinical Mouse Models
title_fullStr The Role of Phytochemicals and Gut Microbiome in Atherosclerosis in Preclinical Mouse Models
title_full_unstemmed The Role of Phytochemicals and Gut Microbiome in Atherosclerosis in Preclinical Mouse Models
title_short The Role of Phytochemicals and Gut Microbiome in Atherosclerosis in Preclinical Mouse Models
title_sort role of phytochemicals and gut microbiome in atherosclerosis in preclinical mouse models
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005405/
https://www.ncbi.nlm.nih.gov/pubmed/36904211
http://dx.doi.org/10.3390/nu15051212
work_keys_str_mv AT centnerannm theroleofphytochemicalsandgutmicrobiomeinatherosclerosisinpreclinicalmousemodels
AT khalilileila theroleofphytochemicalsandgutmicrobiomeinatherosclerosisinpreclinicalmousemodels
AT ukhanovvladimir theroleofphytochemicalsandgutmicrobiomeinatherosclerosisinpreclinicalmousemodels
AT kadyansaurabh theroleofphytochemicalsandgutmicrobiomeinatherosclerosisinpreclinicalmousemodels
AT nagpalravinder theroleofphytochemicalsandgutmicrobiomeinatherosclerosisinpreclinicalmousemodels
AT salazargloria theroleofphytochemicalsandgutmicrobiomeinatherosclerosisinpreclinicalmousemodels
AT centnerannm roleofphytochemicalsandgutmicrobiomeinatherosclerosisinpreclinicalmousemodels
AT khalilileila roleofphytochemicalsandgutmicrobiomeinatherosclerosisinpreclinicalmousemodels
AT ukhanovvladimir roleofphytochemicalsandgutmicrobiomeinatherosclerosisinpreclinicalmousemodels
AT kadyansaurabh roleofphytochemicalsandgutmicrobiomeinatherosclerosisinpreclinicalmousemodels
AT nagpalravinder roleofphytochemicalsandgutmicrobiomeinatherosclerosisinpreclinicalmousemodels
AT salazargloria roleofphytochemicalsandgutmicrobiomeinatherosclerosisinpreclinicalmousemodels